David B. Musket, Director at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 410 shares at $2.75 ($1K) on 2023-10-12, disclosed to the SEC on 2023-10-13.
Open-market purchase of $1k CAPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CAPR | SELL | 2022-07-01 | $213K | — | Filing → |
| CAPR | SELL | 2022-06-29 | $79K | — | Filing → |
| CAPR | BUY | 2017-05-11 | $78K | — | Filing → |